Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
New 3D structure could help design future drugs against cancer
A team of scientists has created a three-dimensional map showing how a small molecule with…
Failed clinical trial leads to scientific breakthrough
It’s not often that a failed clinical trial leads to a scientific breakthrough. When patients…
Evidence suggests cancer is not as purely genetic as once thought
While cancer is a genetic disease, the genetic component is just one piece of the…
Secrets of lung cancer spread found in patients’ blood and biopsies
- ESMO 2019: Mesothelioma trial suggests immunotherapy as an alternative to chemotherapy
- ESMO 2019: Blood test can replace invasive biopsy for more patients with lung cancer
- Protected: Immunotherapy combination now PBS listed for first-line treatment of metastatic non-squamous non-small cell lung cancer (1,2)
Time doesn’t heal all wounds: how DNA damage as we age causes cancer
Ian Majewski, Walter and Eliza Hall Institute and Edward Chew, Walter and Eliza Hall Institute As we age, our bodies…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.